Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2027 16
Figure 4. Europe Biosurgery Market, 2017-2027, $ mn 18
Figure 5. Impact of COVID-19 on Business 21
Figure 6. Primary Drivers and Impact Factors of Europe Biosurgery Market 23
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 26
Figure 8. Primary Restraints and Impact Factors of Europe Biosurgery Market 27
Figure 9. Investment Opportunity Analysis 31
Figure 10. Porter’s Fiver Forces Analysis of Europe Biosurgery Market 34
Figure 11. Breakdown of Europe Biosurgery Market by Product, 2020-2027, % of Revenue 38
Figure 12. Contribution to Europe 2021-2027 Cumulative Revenue by Product, Value ($ mn) and Share (%) 39
Figure 13. Europe Biosurgery Market: Hemostatic Agents, 2017-2027, $ mn 40
Figure 14. Europe Biosurgery Market: Bone-graft Substitutes, 2017-2027, $ mn 41
Figure 15. Europe Biosurgery Market: Synthetic Graft Extender, 2017-2027, $ mn 42
Figure 16. Europe Biosurgery Market: Demineralized Bone Matrix, 2017-2027, $ mn 43
Figure 17. Europe Biosurgery Market: Bone Morphogenetic Proteins, 2017-2027, $ mn 44
Figure 18. Europe Biosurgery Market: Cell-Based Matrices, 2017-2027, $ mn 45
Figure 19. Europe Biosurgery Market: Surgical Sealants and Adhesives, 2017-2027, $ mn 46
Figure 20. Europe Biosurgery Market: Natural Surgical Sealing Agents, 2017-2027, $ mn 47
Figure 21. Europe Biosurgery Market: Synthetic Surgical Sealing Agents, 2017-2027, $ mn 48
Figure 22. Europe Biosurgery Market: Soft-tissue Attachments, 2017-2027, $ mn 49
Figure 23. Europe Biosurgery Market: Natural & Biological Mesh/Patch, 2017-2027, $ mn 50
Figure 24. Europe Biosurgery Market: Synthetic Mesh/Patch, 2017-2027, $ mn 51
Figure 25. Europe Biosurgery Market: Adhesion Barriers, 2017-2027, $ mn 52
Figure 26. Europe Biosurgery Market: Natural Adhesion Barriers, 2017-2027, $ mn 53
Figure 27. Europe Biosurgery Market: Synthetic Adhesion Barriers, 2017-2027, $ mn 54
Figure 28. Europe Biosurgery Market: Staple Line Reinforcement, 2017-2027, $ mn 55
Figure 29. Breakdown of Europe Biosurgery Market by Source Type, 2020-2027, % of Revenue 56
Figure 30. Contribution to Europe 2021-2027 Cumulative Revenue by Source Type, Value ($ mn) and Share (%) 57
Figure 31. Europe Biosurgery Market: Natural/Biological Products, 2017-2027, $ mn 58
Figure 32. Europe Biosurgery Market: Synthetic Products, 2017-2027, $ mn 59
Figure 33. Breakdown of Europe Biosurgery Market by Application, 2020-2027, % of Revenue 62
Figure 34. Contribution to Europe 2021-2027 Cumulative Revenue by Application, Value ($ mn) and Share (%) 62
Figure 35. Europe Biosurgery Market: Orthopedic Surgery, 2017-2027, $ mn 63
Figure 36. Europe Biosurgery Market: General Surgery, 2017-2027, $ mn 64
Figure 37. Europe Biosurgery Market: Neurological Surgery, 2017-2027, $ mn 65
Figure 38. Europe Biosurgery Market: Cardiovascular Surgery, 2017-2027, $ mn 66
Figure 39. Europe Biosurgery Market: Gynecological Surgery, 2017-2027, $ mn 67
Figure 40. Europe Biosurgery Market: Other Applications, 2017-2027, $ mn 68
Figure 41. Breakdown of European Biosurgery Market by Country, 2020 and 2027, % of Revenue 70
Figure 42. Contribution to Europe 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%) 71
Figure 43. Biosurgery Market in UK, 2017-2027, $ mn 72
Figure 44. Biosurgery Market in France, 2017-2027, $ mn 74
Figure 45. Biosurgery Market in Germany, 2017-2027, $ mn 76
Figure 46. Biosurgery Market in Spain, 2017-2027, $ mn 78
Figure 47. Biosurgery Market in Italy, 2017-2027, $ mn 80
Figure 48. Biosurgery Market in Russia, 2017-2027, $ mn 82
Figure 49. Biosurgery Market in Rest of Europe, 2017-2027, $ mn 84
Figure 50. Growth Stage of Europe Biosurgery Industry over the Forecast Period 86
Europe biosurgery market accounted for $3,610.6 million in 2020 and will grow by 6.2% annually over 2020-2027 owing to the growth in joint reconstruction and spinal fusion, the increasing number of surgeries especially minimally invasive surgeries due to lifestyle disorders and the rise in the overweight & aging population. Highlighted with 34 tables and 50 figures, this 104-page report “Europe Biosurgery Market 2020-2027 by Product, Source Type (Natural, Synthetic), Application (Orthopedic, General, Neurological, Cardiovascular), and Country: Trend Outlook and Growth Opportunity” is based on a comprehensive research of the entire Europe biosurgery market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2027 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe biosurgery market in every aspect of the classification from perspectives of Product, Source Type, Application, and Country. Based on Product, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section. • Hemostatic Agents • Bone-graft Substitutes • Synthetic Graft Extender • Demineralized Bone Matrix • Bone Morphogenetic Proteins • Cell-Based Matrices • Surgical Sealants and Adhesives • Natural Surgical Sealing Agents • Synthetic Surgical Sealing Agents • Soft-tissue Attachments • Natural & Biological Mesh/Patch • Synthetic Mesh/Patch • Adhesion Barriers • Natural Adhesion Barriers • Synthetic Adhesion Barriers • Staple Line Reinforcement Based on Source Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section. • Natural/Biological Products • Synthetic Products Based on Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section. • Orthopedic Surgery • General Surgery • Neurological Surgery • Cardiovascular Surgery • Gynecological Surgery • Other Applications Geographically, the following national/local markets are fully investigated: • Germany • UK • France • Spain • Italy • Russia • Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2017-2027. The breakdown of key national markets by Product, Source Type, and Application over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Key Players (this may not be a complete list and extra companies can be added upon request): B. Braun Melsungen AG Baxter International, Inc. Becton, Dickinson and Company (C.R. Bard) Betatech Medical CryoLife Inc. CSL Limited Hemostasis LLC Integra Lifesciences Holdings Corporation Johnson & Johnson Medtronic PLC Pfizer, Inc. Sanofi S.A. Stryker Corporation (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Read More